Physician
Oncology
Dr. Jamie K. Waselenko, MD
|
|
Give Review
Jamie Waselenko practices Oncology. He went to medical school at Uniformed Services University of the Health Sciences. Uniformed Services University of the Health Sciences is ranked 72 in research and 47 in primary care medicine He over the years received 1 awards: "Fellow (FACP)". Jamie Waselenko is a published MD as well. He has 23 publications published. The latest was: Women with thrombophilia: assessing the risks for thrombosis with oral contraceptives or hormone replacement therapy. He accepts Medicare payments and is listed with Medicare.gov.
Publications
- Acute radiation injury: contingency planning for triage, supportive care, and transplantation.
- Medical management of radiological casualties.
- Thrombotic microangiopathy (TMA) and stroke due to human herpesvirus-6 (HHV-6) reactivation in an adult receiving high-dose melphalan with autologous peripheral stem c...
- The hematologist and radiation casualties.
- Management of progressive metastatic prostate Cancer.
- Medical management of patients with multiple organ dysfunction arising from Acute radiation syndrome.
- Carboxyamido-triazole (CAI)--a novel "static" signal transduction inhibitor induces apoptosis in human B-cell chronic lymphocytic Leukemia cells.
- Gemcitabine demonstrates in vitro activity against human B-cell chronic lymphocytic Leukemia.
- Rituximab using a thrice weekly dosing schedule in B-cell chronic lymphocytic Leukemia and small lymphocytic lymphoma demonstrates clinical activity and acceptable tox...
- Novel therapies for chronic lymphocytic Leukemia in the 21st century.
- Pentostatin (Nipent) and chlorambucil with granulocyte-macrophage colony-stimulating factor support for patients with previously untreated, treated, and fludarabine-re...
- Theophylline, pentostatin (Nipent), and chlorambucil: a dose-escalation study targeting intrinsic biologic resistance mechanisms in patients with relapsed lymphoprolif...
- Depsipeptide (FR901228): a novel therapeutic agent with selective, in vitro activity against human B-cell chronic lymphocytic Leukemia cells.
- Preservation of nucleic acids for polymerase chain reaction after prolonged storage at room temperature.
- Stem-cell transplantation in chronic lymphocytic Leukemia: the time for designing randomized studies has arrived.
- Rituximab therapy in hematologic malignancy patients with circulating blood tumor Cells: association with increased infusion-related side effects and rapid blood tumor...
- Women with thrombophilia: assessing the risks for Thrombosis with oral contraceptives or hormone replacement therapy.
- Flavopiridol induces apoptosis in chronic lymphocytic Leukemia cells via activation of caspase-3 without evidence of bcl-2 modulation or dependence on functional p53.
- Suramin keratosis: a unique skin eruption in a patient receiving suramin for metastatic prostate Cancer.
- Medical management of the Acute radiation syndrome: recommendations of the Strategic National Stockpile Radiation Working Group.
- Post-transplant interleukin-2 in patients with low-grade lymphoid neoplasms previously treated with fludarabine is limited by hematologic toxicity.
- A phase I/II study examining pentostatin, chlorambucil, and theophylline in patients with relapsed chronic lymphocytic Leukemia and non-Hodgkin''s lymphoma.
Procedures Preformed
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- Plasmapheresis
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Pathway X Bronze Direct CACA IN HIX
- Pathway X Tiered Hosp/Ind Direct Access OH
- Anthem Blue Cross Blue Shield HMO
- Anthem Blue Cross Blue Shield PPO
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Cofinity PPO
- Choice Care PPO
- Preferred PPO
- Medical Mutual of Ohio POS
- MultiPlan PPO
- PHCS Network PPO
- Mutual of Omaha
- Sagamore Plus
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
Awards
- Fellow (FACP)
Education
-
National Capital Consortium -
Madigan Healthcare System -
Uniformed Services University of the Health Sciences
Hospital
-
Christ Hospital
Drug Facts
| NPI NUMBER | 1710911847 | |
| NPPES Provider LastName | WASELENKO | |
| NPPES Provider FirstName | JAMIE | |
| NPPES Provider ZIPCode | 452092276 | |
| NPPES Provider State | OH | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 1504.0 | |
| Distinct Opioid Count | 4.0 | |
| Opioid Claim Count | 88.0 | |
| Percent Opioid Claims | 5.85 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1710911847 |
| Last Name Of The Provider | WASELENKO |
| First Name Of The Provider | JAMIE |
| View All |
Similar Doctors
|
|
Dr. Colleen M. Darnell, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ehsan Malek, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael Justin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Philip D. Leming, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brian A. Mannion, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Edward B. Silberstein, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Leslie Oleksowicz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mark Andolina, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Edward R. Broun, MD |
|
|
Dr. Arthur J. Craig, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard L. McMasters, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tahir Latif, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Slobodan M. Stanisic, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Luckson Mathieu, MD
This Doctor is OpenDoctor Recommended.
|